Linezolid-associated peripheral and optic neuropathy in children

Pediatrics

Volumn 127, Issue 6, 2011, Pages

  Nambiar, Sumathi ^a   Rellosa, Neil ^a   Wassel, Ronald T ^a   Borders Hemphill, Vicky ^a   Bradley, John S ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Linezolid; Optic neuropathy; Pediatrics; Peripheral neuropathy

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; ESOMEPRAZOLE; GAMMA1B INTERFERON; GATIFLOXACIN; LANSOPRAZOLE; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OFLOXACIN; STREPTOMYCIN; VANCOMYCIN;

ACIDOSIS; ADOLESCENT; ADVERSE OUTCOME; ANEMIA; ARTICLE; BACTERIAL MENINGITIS; BOVINE TUBERCULOSIS; CHILD; CHILD HEALTH; COLOR BLINDNESS; CYSTIC FIBROSIS; DRUG INDUCED DISEASE; DRUG USE; FEMALE; FOOT DISEASE; HOSPITAL PATIENT; HUMAN; JAW DISEASE; KIDNEY ABSCESS; LEUKOPENIA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MASTOIDITIS; NOCARDIOSIS; OPTIC NERVE DISEASE; OSTEOMYELITIS; OUTPATIENT; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SPONDYLITIS; SYMPTOMATOLOGY; VISUAL ACUITY; WEAKNESS;

ACETAMIDES; ADOLESCENT; ANTI-INFECTIVE AGENTS; ARGENTINA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTION; MALE; OPTIC NERVE DISEASES; OXAZOLIDINONES; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK FACTORS;

EID: 79957885896     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2125     Document Type: Article

References (19)

1. US Food and Drug Administration. Highlights of prescribing information-Zyvox. Available at: www.accessdata.fda.gov/drugsatfda-docs/ label/2008/021130s016,021131s013,021132s 014lbl.pdf. Accessed June 18, 2010
2. Linam WM, Wesselkamper K, Gerber MA. Peripheral neuropathy in an adolescent treated with linezolid. Pediatr Infect Dis J. 2009;28(2):149-151
3. Brennan K, Jones BL, Jackson L. Auditory nerve neuropathy in a neonate after linezolid treatment. Pediatr Infect Dis J. 2009;28(2):169
4. US Food and Drug Administration. Med- Watch: The Food and Drug Administration Safety Information and Adverse Event Reporting Program. Available at: www.fda. gov/medwatch/. Accessed July 22, 2009
5. US Food and Drug Administration. CFR - Code of Federal Regulations, Title 21, Volume 5. Available at: www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch. cfm?fr=314.80. Accessed July 22, 2009
6. Medical Dictionary for Regulatory Activities Maintenance and Support Services Organization. Welcome to MedDRA and the MSSO. Available at: www.meddramsso.com/. Accessed June 8, 2010
7. Mongkolrattanothai K, Ramakrishnan S, Zagardo M, Gray B. Ventriculitis and choroid plexitis caused by multidrug-resistant Nocardia pseudobrasiliensis. Pediatr Infect Dis J. 2008;27(7):666-668
8. Rosenzweig SD, Yancoski J, Bernasconi A, et al. Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome. J Infect. 2006;52(3):e69-e72 (Pubitemid 43286193)
9. Javaheri M, Khurana RN, O'hearn TM, Lai MM, Sadun AA. Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol. 2007;91(1):111-115
10. Beekmann SE, Gilbert DN, Polgreen PM, IDSA Emerging Infections Network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis. 2008;62(4):407-410
11. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis. 2004;4(8):528-531 (Pubitemid 39077924)
12. Azamfirei L, Copotoiu R, Branzaniuc K, Szederjesi J, Copotoiu R, Berteanu C. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy. Pharmacoepidemiol Drug Saf. 2007;16(4):402-404 (Pubitemid 46656861)
13. Lee E, Burger S, Shah J, et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis. 2003;37(10):1389-1391 (Pubitemid 37433638)
14. Joshi L, Taylor SR, Large O, Yacoub S, Lightman S. A case of optic neuropathy after short-term linezolid use in a patient with acute lymphocytic leukemia. Clin Infect Dis. 2009;48(7):e73-e74
15. Narita M, Tsuji BT, Yu VL. Linazolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy. 2007;27:1189-1197 (Pubitemid 47173662)
16. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med. 1984;101(1):92-104 (Pubitemid 14088076)
17. Cohen JS. Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacother. 2001;35(12):1540-1547 (Pubitemid 34027449)
18. US Food and Drug Administration. Available at: www.accessdata.fda.gov/ drugsatfda- docs/label/2008/021721s020-020635s57- 020634s52-lbl.pdf. Accessed June 23, 2010
19. Daily Med, Current Medication Information. Available at: http://dailymed.nlm.nih.gov/ dailymed/drugInfo.cfm?id=13231. Accessed June 23, 2010